The focus is on their time-dependent effects on key regulatory proteins involved in tumor progression, including epidermal growth factor receptor (EGFR) for proliferation, vascular endothelial growth factor (VEGF) for angiogenesis, and caspase-3 for apoptosis. The gene discussed is VEGFA; the disease is neoplasm.